BACKGROUND: In the United States, and particularly in South Carolina, African-American women suffer disproportionately higher mortality rates from breast cancer than European-American women. The timeliness of patient adherence to the follow-up of mammographic abnormalities may influence prognosis and survival. The objective of the current investigation was to examine racial differences in the completion and completion time of a diagnostic workup after the finding of a suspicious breast abnormality. METHODS: Study participants of the Best Chance Network, a statewide service program that provides free mammography screening to economically disadvantaged and medically underserved women, were included in the study. Racial differences in tumor characteristics and adherence to recommended workup were tested using chi-square tests and t tests. Logistic and Cox regression modeling was used to assess the relation between workup completion and other factors among African-American women and European-American women. RESULTS: Completion of the workup was associated with the number of previous procedures and income, and no significant differences were noted by race. The amount of time to completion of the workup was influenced by previous procedures, income, and race. After accounting for completion time, African-American women were 12% less likely than European-American women to complete the recommended workup (hazard ratio, 0.88; P=.01). CONCLUSIONS: The results from this study established a racial disparity in the time to completion of a diagnostic workup among Best Chance Network participants. These findings highlight the importance of understanding the factors associated with delays in and adherence to completing the recommended workup when breast abnormalities are detected in mammograms. Copyright (c) 2009 American Cancer Society.
BACKGROUND: In the United States, and particularly in South Carolina, African-American women suffer disproportionately higher mortality rates from breast cancer than European-American women. The timeliness of patient adherence to the follow-up of mammographic abnormalities may influence prognosis and survival. The objective of the current investigation was to examine racial differences in the completion and completion time of a diagnostic workup after the finding of a suspicious breast abnormality. METHODS: Study participants of the Best Chance Network, a statewide service program that provides free mammography screening to economically disadvantaged and medically underserved women, were included in the study. Racial differences in tumor characteristics and adherence to recommended workup were tested using chi-square tests and t tests. Logistic and Cox regression modeling was used to assess the relation between workup completion and other factors among African-American women and European-American women. RESULTS: Completion of the workup was associated with the number of previous procedures and income, and no significant differences were noted by race. The amount of time to completion of the workup was influenced by previous procedures, income, and race. After accounting for completion time, African-American women were 12% less likely than European-American women to complete the recommended workup (hazard ratio, 0.88; P=.01). CONCLUSIONS: The results from this study established a racial disparity in the time to completion of a diagnostic workup among Best Chance Network participants. These findings highlight the importance of understanding the factors associated with delays in and adherence to completing the recommended workup when breast abnormalities are detected in mammograms. Copyright (c) 2009 American Cancer Society.
Authors: Beth A Jones; Amy Dailey; Lisa Calvocoressi; Kam Reams; Stanislav V Kasl; Carol Lee; Helen Hsu Journal: Cancer Causes Control Date: 2005-09 Impact factor: 2.506
Authors: Jon F Kerner; Janelle Guirguis-Blake; Kevin D Hennessy; Paul J Brounstein; Cynthia Vinson; Randy H Schwartz; Bradford A Myers; Peter Briss Journal: Cancer Causes Control Date: 2005-10 Impact factor: 2.506
Authors: Sheila Weinmann; Stephen H Taplin; Joyce Gilbert; Robert K Beverly; Ann M Geiger; Marianne Ulcickas Yood; Judy Mouchawar; M Michele Manos; Jane G Zapka; Emily Westbrook; William E Barlow Journal: J Natl Cancer Inst Monogr Date: 2005
Authors: Swann Arp Adams; James R Hebert; Susan Bolick-Aldrich; Virginie G Daguise; Catishia M Mosley; Mary V Modayil; Sondra H Berger; Jane Teas; Michael Mitas; Joan E Cunningham; Susan E Steck; James Burch; William M Butler; Marie-Josephe D Horner; Heather M Brandt Journal: J S C Med Assoc Date: 2006-08
Authors: Kristen J Wells; Cathy D Meade; Ercilia Calcano; Ji-Hyun Lee; Desiree Rivers; Richard G Roetzheim Journal: J Cancer Educ Date: 2011-12 Impact factor: 2.037
Authors: Joan E Cunningham; Christine A Walters; Elizabeth G Hill; Marvella E Ford; Tiffany Barker-Elamin; Charles L Bennett Journal: Breast Cancer Res Treat Date: 2012-12-13 Impact factor: 4.872
Authors: Yamile Molina; Bridgette H Hempstead; Jacci Thompson-Dodd; Shauna Rae Weatherby; Claire Dunbar; Sarah D Hohl; Rachel C Malen; Rachel M Ceballos Journal: J Cancer Educ Date: 2015-09 Impact factor: 2.037
Authors: Erica T Warner; Rulla M Tamimi; Melissa E Hughes; Rebecca A Ottesen; Yu-Ning Wong; Stephen B Edge; Richard L Theriault; Douglas W Blayney; Joyce C Niland; Eric P Winer; Jane C Weeks; Ann H Partridge Journal: Breast Cancer Res Treat Date: 2012-10-26 Impact factor: 4.872
Authors: Richard G Roetzheim; Ji-Hyun Lee; Ercilia R Calcano; Cathy D Meade; William J Fulp; Kristen J Wells Journal: J Health Care Poor Underserved Date: 2012-08
Authors: Kristen J Wells; Ji-Hyun Lee; Ercilia R Calcano; Cathy D Meade; Marlene Rivera; William J Fulp; Richard G Roetzheim Journal: Cancer Epidemiol Biomarkers Prev Date: 2012-10 Impact factor: 4.254